摘要
目的探讨大环内酯类抗生素在婴幼儿支气管肺炎治疗中的临床应用价值。方法选择我院2012年7月-2013年1月间患有肺炎的新生儿56例，随机将患儿分成两组，治疗组28例，采用红霉素治疗；对照组28例，采用阿奇霉素序贯疗法治疗。将两组的不良反应发生率及临床治疗效果进行对比。结果实验组的临床总有效率明显高出对照组（P〈0．05）；两组的不良反应差异无统计学意义（P〉0．05）。结论临床选用大环内酯类抗生素在治疗婴幼儿支气管肺炎取得的效果显著，推荐广泛使用。
Objective To investigate the clinical application value of macrolide antibiotics in the treatment of infants with bronchopneumonia. Methods 56 infants with pneumonia selected from July 2012 to January 2013 in our hospital were randomly divided into two groups.28 cases in the treatment group were treated with erythromycin therapy;28 cases in the control group were treated with azithromycin sequential therapy.The incidence of adverse reactions and clinical curative effect of the two groups were compared. Results The total effective rate in the experimental group was significantly higher than that in the control group（P 〈 0.05）;The difference in adverse reactions betWeen the two groups was no significant（P 〉 0.05）. Conclusion The clinical use of macrolide antibiotics in the treatment of infants with bronchopneumonia has significant effect, and is widely used and recommended.
出处
《中国医药科学》
2013年第18期87-88,共2页
China Medicine And Pharmacy
关键词
大环内酯类抗生素
幼儿支气管炎
疗效
价值
Macrolide antibiotics
Infants with bronchopneumonia
Curative effect
Value
